Related references
Note: Only part of the references are listed.How much apoptosis does carbon monoxide poisoning cause? Primary clinical soluble TWEAK protein level study
N. Dindar Badem et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2019)
Sputum TWEAK expression correlates with severity and degree of control in non-eosinophilic childhood asthma
Soo Yeon Kim et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway
Cuimin Zhu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Combination of TWEAK and TGF-β1 induces the production of TSLP, RANTES, and TARC in BEAS-2B human bronchial epithelial cells during epithelial-mesenchymal transition
Kei Matsuno et al.
EXPERIMENTAL LUNG RESEARCH (2018)
Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
Xavier Escote et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction
Silke Ryan
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
Shuichi Sato et al.
FASEB JOURNAL (2015)
Regulation of tissue responses: the TWEAK/Fn14 pathway and other TNF/TNFR superfamily members that activate non-canonical NFκB signaling
Linda C. Burkly
FRONTIERS IN IMMUNOLOGY (2015)
Reduced circulating levels of TWEAK are associated with Gestational Diabetes Mellitus
Inmaculada Simon-Muela et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells
Yukinari Itoigawa et al.
RESPIRATORY RESEARCH (2015)
Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
Andres Diaz-Lopez et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Deletion of TNF-like Weak Inducer of Apoptosis (TWEAK) Protects Mice from Adipose and Systemic Impacts of Severe Obesity
Grace Bennett et al.
OBESITY (2014)
Serum sTWEAK Concentrations and Risk of Developing Type 2 Diabetes in a High Cardiovascular Risk Population: A Nested Case-Control Study
Andres Diaz-Lopez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Rise of Soluble TWEAK Levels in Severely Obese Subjects After Bariatric Surgery May Affect Adipocyte-Cytokine Production Induced by TNFα
Elsa Maymo-Masip et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
TWEAK: a new player obesity and diabetes
Joan Vendrell et al.
FRONTIERS IN IMMUNOLOGY (2013)
Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
Gemma Llaurado et al.
PLOS ONE (2012)
Tumor Necrosis-Like Weak Inducer of Apoptosis as a Proinflammatory Cytokine in Human Adipocyte Cells: Up-Regulation in Severe Obesity Is Mediated by Inflammation But Not Hypoxia
Joan Vendrell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
Mahmut Ilker Yilmaz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of TWEAK (TNF Superfamily Member 12) on Differentiation, Metabolism, and Secretory Function of Human Primary Preadipocytes and Adipocytes
Gabriele Tiller et al.
ENDOCRINOLOGY (2009)
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease
Susan Kralisch et al.
ATHEROSCLEROSIS (2008)
Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue.: Relationship with other inflammatory cytokines in obesity
MR Chacón et al.
CYTOKINE (2006)
Obstructive sleep apnoea syndrome - an oxidative stress disorder
L Lavie
SLEEP MEDICINE REVIEWS (2003)
Share Paper
